Overall hrHPV prevalence peaked at 22 years, with a peak prevalence of 24%.
The overall hrHPV prevalence peaked at the age of 22 with peak prevalence of 24%.
And in six of those countries there was a decline of 25% or more from peak prevalence among those aged between 15 and 24.
Peak prevalence in dogs is at 7 10 years, females are twice as frequent.
The peak prevalence is during adulthood; however, they can occur at all ages and have a female predilection.
Our findings are also consistent with previous published studies in that migraine has a peak prevalence between 25 and 50 years [9, 11, 23, 24].
Further, migraine was more than twice more common in female than in men, with a peak prevalence in those aged 31 50 years.
The disease is more frequent in females (3:1 female-to-male ratio) and has its peak prevalence between the ages of 22 and 55 years [5, 6].
We assumed that field estimates correspond to peak prevalence.
The peak prevalence of the disease is among patients 60 70 years of age.
Higher infectious contact or infection rates produced more rapid epidemics with higher peak prevalence.
